OR WAIT 15 SECS
© 2020 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2020 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
June 01, 2020
The only way for pharma companies to know where to focus their COVID-19 R&D efforts is for the industry to have access to real-time, real-world evidence of what’s working to keep people alive, write Travis Leonardi and William Kirsh.
May 18, 2020
The need for statisticians, mathematicians, and computer and data scientists to collaborate on modern methods
for “substantial evidence” in drug development is critical.
March 01, 2020
The evolving challenges and new opportunities from the latest wave of change in clinical data management practice.
September 01, 2019
Organizations that continue to disregard the technological needs of one of the industry’s core audiences run the risk of having their trials ignored.
June 01, 2019
Undertaking an assessment of the POS can be coupled with the product profile and safety assessments of compounds prior to launching a clinical trial.
May 01, 2019
What small “nudges” can serve as reminders and relevant motivators to help patients meet their goals, talk to a physician, explore a clinical trial, or stick with a treatment?
April 01, 2019
The “citizen data scientist” is the person with no official data scientist training who uses the latest tools and technologies to handle data wrangling duties, analyze data, and create reports and models.
March 01, 2019
Patient advocacy organizations are swaying away from a traditional model of granting academic researchers to now supporting biotechnology and pharma companies.
December 01, 2018
The availability of FHIR-based APIs enabling patients to access and use their healthcare data for multiple purposes has opened a door to an entirely new world of opportunities for partnering with patients on clinical studies.
November 01, 2018
Pharma and diagnostics companies need to strengthen alignment in Alzheimer’s disease research-to help turn science and data into actionable medical innovations.
October 01, 2018
Key tips and resources to help evade the common traps of market landscaping-today an increasingly high-stakes and comprehensive task during clinical development.
September 01, 2018
To support complex in-home clinical research and investigative sites, well-designed trials must produce the same high-quality data as traditional sites.
June 01, 2018
With more common cancers now increasingly broken down by specific genomic defects, the future of research for any cancer is entirely, and unequivocally, molecular.
March 01, 2018
Digital media is becoming a crucial vehicle for finding “Patient X” for rare disease drug trials. Three areas in particular where digital media is helping with the detective work are explored.
February 01, 2018
To vie for success in the market for dermatologic therapies, companies developing biologics must navigate a series of significant challenges, including patient compliance and safety.
December 01, 2017
The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
October 01, 2017
Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.
August 01, 2017
As industry headlines buzz with drug pricing uncertainty and M&A speculation, sponsors can boost productivity on the R&D front through more conscious management of outsourcing spend.
June 01, 2017
As Applied Clinical Trials celebrates its 25th birthday, longtime contributing author and columnist Ken Getz looks at the four truisms that still drive clinical trial operations today and into the future.
April 01, 2017
The language in Europe's Regulation (EU) 536/2014 regarding ethical review of protocols is concerning.